Flagship Harbor Advisors LLC Has $1.41 Million Holdings in CVS Health Co. (NYSE:CVS)

Flagship Harbor Advisors LLC grew its position in CVS Health Co. (NYSE:CVS) by 9.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,456 shares of the pharmacy operator’s stock after buying an additional 2,603 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in CVS Health were worth $1,412,000 at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in the company. apricus wealth LLC increased its stake in shares of CVS Health by 2.1% in the fourth quarter. apricus wealth LLC now owns 37,055 shares of the pharmacy operator’s stock worth $1,663,000 after acquiring an additional 765 shares during the last quarter. Exchange Traded Concepts LLC increased its position in CVS Health by 17.9% in the 4th quarter. Exchange Traded Concepts LLC now owns 17,514 shares of the pharmacy operator’s stock worth $786,000 after purchasing an additional 2,661 shares during the last quarter. CX Institutional raised its stake in shares of CVS Health by 35.1% during the 4th quarter. CX Institutional now owns 100,787 shares of the pharmacy operator’s stock worth $4,524,000 after purchasing an additional 26,178 shares in the last quarter. Southland Equity Partners LLC lifted its holdings in shares of CVS Health by 44.0% during the 4th quarter. Southland Equity Partners LLC now owns 4,985 shares of the pharmacy operator’s stock valued at $224,000 after buying an additional 1,523 shares during the last quarter. Finally, Secure Asset Management LLC increased its holdings in CVS Health by 13.8% in the fourth quarter. Secure Asset Management LLC now owns 33,271 shares of the pharmacy operator’s stock worth $1,494,000 after buying an additional 4,024 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have issued reports on CVS. Evercore ISI lifted their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an “outperform” rating in a research note on Tuesday, October 8th. Deutsche Bank Aktiengesellschaft raised shares of CVS Health from a “hold” rating to a “buy” rating and set a $66.00 target price on the stock in a research report on Tuesday, December 3rd. Mizuho reduced their price target on CVS Health from $73.00 to $66.00 and set an “outperform” rating for the company in a research report on Thursday, October 24th. TD Cowen raised their price objective on CVS Health from $73.00 to $80.00 and gave the company a “buy” rating in a research note on Monday, November 25th. Finally, Royal Bank of Canada decreased their target price on CVS Health from $68.00 to $58.00 and set an “outperform” rating for the company in a research report on Friday, November 15th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $68.71.

CVS Health Stock Up 1.6 %

CVS stock opened at $54.71 on Monday. CVS Health Co. has a twelve month low of $43.56 and a twelve month high of $80.75. The company has a quick ratio of 0.59, a current ratio of 0.80 and a debt-to-equity ratio of 0.80. The company has a market cap of $68.84 billion, a PE ratio of 13.88, a price-to-earnings-growth ratio of 0.80 and a beta of 0.59. The business’s 50-day simple moving average is $51.24 and its 200 day simple moving average is $56.21.

CVS Health (NYSE:CVS) last released its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $0.01. The business had revenue of $95.43 billion for the quarter, compared to analysts’ expectations of $92.72 billion. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. CVS Health’s quarterly revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business posted $2.21 earnings per share. On average, research analysts anticipate that CVS Health Co. will post 5.22 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, February 3rd. Stockholders of record on Thursday, January 23rd will be issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 4.86%. The ex-dividend date is Thursday, January 23rd. CVS Health’s payout ratio is 67.51%.

About CVS Health

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.